STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Aldeyra Therapeutics, Inc.

Filed

August 2, 2022

Period of Report

July 29, 2022

Accession Number

0001062993-22-017083